Insider Selling: Mettler-Toledo International Inc. (MTD) Insider Sells 3,568 Shares of Stock

Mettler-Toledo International Inc. (NYSE:MTD) insider Waldemar Rauch sold 3,568 shares of the business’s stock in a transaction on Friday, March 9th. The stock was sold at an average price of $616.72, for a total value of $2,200,456.96. Following the transaction, the insider now directly owns 3,368 shares of the company’s stock, valued at $2,077,112.96. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Waldemar Rauch also recently made the following trade(s):

How to Become a New Pot Stock Millionaire
  • On Tuesday, February 13th, Waldemar Rauch sold 4,500 shares of Mettler-Toledo International stock. The stock was sold at an average price of $614.18, for a total value of $2,763,810.00.

Shares of Mettler-Toledo International Inc. (NYSE MTD) traded up $3.98 during midday trading on Monday, hitting $619.98. The company had a trading volume of 58,495 shares, compared to its average volume of 166,924. The firm has a market cap of $15,691.27, a PE ratio of 35.02, a PEG ratio of 2.55 and a beta of 1.14. The company has a current ratio of 1.46, a quick ratio of 1.09 and a debt-to-equity ratio of 1.75. Mettler-Toledo International Inc. has a 1 year low of $471.14 and a 1 year high of $697.26.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, February 8th. The medical instruments supplier reported $5.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.93 by $0.04. The firm had revenue of $778.03 million during the quarter, compared to analysts’ expectations of $764.26 million. Mettler-Toledo International had a return on equity of 94.54% and a net margin of 13.80%. The business’s revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm earned $5.28 EPS. research analysts forecast that Mettler-Toledo International Inc. will post 20.17 EPS for the current year.

Several research analysts recently commented on MTD shares. Deutsche Bank boosted their target price on Mettler-Toledo International from $600.00 to $630.00 and gave the stock a “hold” rating in a research note on Thursday, March 1st. Morgan Stanley boosted their target price on Mettler-Toledo International from $550.00 to $580.00 and gave the stock an “equal weight” rating in a research note on Friday, February 9th. Evercore ISI began coverage on Mettler-Toledo International in a research report on Wednesday, January 3rd. They set an “in-line” rating and a $625.00 price objective for the company. Robert W. Baird lowered their price objective on Mettler-Toledo International from $675.00 to $630.00 and set a “neutral” rating for the company in a research report on Friday, February 9th. Finally, Barclays began coverage on Mettler-Toledo International in a research report on Thursday, January 4th. They set an “equal weight” rating and a $625.00 price objective for the company. Seven analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Mettler-Toledo International currently has a consensus rating of “Hold” and a consensus target price of $649.30.

Several hedge funds and other institutional investors have recently made changes to their positions in MTD. BlackRock Inc. lifted its stake in shares of Mettler-Toledo International by 2.3% in the fourth quarter. BlackRock Inc. now owns 1,847,591 shares of the medical instruments supplier’s stock worth $1,144,617,000 after acquiring an additional 41,344 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Mettler-Toledo International by 0.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 482,730 shares of the medical instruments supplier’s stock worth $299,061,000 after purchasing an additional 3,876 shares during the last quarter. Russell Investments Group Ltd. increased its stake in shares of Mettler-Toledo International by 2.5% during the 4th quarter. Russell Investments Group Ltd. now owns 328,763 shares of the medical instruments supplier’s stock worth $204,608,000 after purchasing an additional 7,996 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Mettler-Toledo International by 3.5% during the 4th quarter. Geode Capital Management LLC now owns 305,818 shares of the medical instruments supplier’s stock worth $189,106,000 after purchasing an additional 10,258 shares during the last quarter. Finally, Janus Henderson Group PLC increased its stake in shares of Mettler-Toledo International by 20.2% during the 3rd quarter. Janus Henderson Group PLC now owns 243,920 shares of the medical instruments supplier’s stock worth $152,732,000 after purchasing an additional 40,993 shares during the last quarter. 92.17% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Markets Daily and is the sole property of of Markets Daily. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US & international copyright & trademark law. The correct version of this report can be accessed at https://www.themarketsdaily.com/2018/03/12/insider-selling-mettler-toledo-international-inc-mtd-insider-sells-3568-shares-of-stock.html.

About Mettler-Toledo International

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Insider Buying and Selling by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply